Novel Drug Approvals for 2018

No. Drug Name Active Ingredient Approval Date FDA-approved use on approval date 9. Akynzeo fosnetupitant and palonosetron 4/19/2018 To prevent acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy 8. Crysvita burosumab-twza

Novel Drug Approvals for 2017

No. Drug Name Active Ingredient Approval Date FDA-approved use on approval date 46. Giapreza angiotensin II 12/21/2017 To increase blood pressure in adults with septic or other distributive shock Press Release Drug Trials Snapshot 45. Macrilen macimorelin acetate 12/20/2017 For

Novel Drug Approvals for 2016

No. Drug Name Active Ingredient Approval Date FDA-approved use on approval date 22. Spinraza nusinersen 12/23/2016 To treat children and adults with spinal muscular atrophy (SMA) Press Release Drug Trials Snapshot 21. Rubraca rucaparib 12/19/2016 To treat women with a

Novel Drug Approvals for 2015

No. Drug Name Active Ingredient Date FDA-approved use on approval date 45. Zurampic lesinurad 12/22/2015 To treat high blood uric acid levels associated with gout Press Release Drug Trials Snapshot 44. Uptravi selexipag 12/22/2015 To treat pulmonary arterial hypertension Press